# NIIKI PHARMA INC — Form D/A

NIIKI PHARMA INC of HOBOKEN, NJ, a company, filed a Form D amendment with the SEC on 2011-08-10. The offering totals $6.0M, of which $1.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-08-10
- Form: D/A
- Accession: 0001420996-11-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $1.7M
- Remaining: $4.3M
- Investors: 18
- Date of first sale: 2011-02-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-156004

## Issuer

- Name: NIIKI PHARMA INC
- CIK: 0001420996
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 80 RIVER STREET, HOBOKEN, NJ, 07030
- Phone: 201-238-2885

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Ali Ardakani | Director | Hoboken, NJ |
| Hooshmand Sheshbaradaran | Director | Tampa, FL |
| Ali Ardakani | Executive Officer | Hoboken, NJ |
| Hooshmand Sheshbaradaran | Executive Officer | Tampa, FL |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2011-03-01](https://search.stillhousedata.com/formd/0001420996-11-000002) | D | $6.0M | $500K |
| [2010-07-23](https://search.stillhousedata.com/formd/0001420996-10-000003) | D/A | $7.0M | $5.0M |
| [2010-03-11](https://search.stillhousedata.com/formd/0001420996-10-000002) | D/A | $5.0M | $3.8M |

## More

- [CIK 1420996 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1420996&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001420996-11-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.